Peter Lukac
Overview
Explore the profile of Peter Lukac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Riva M, Evertz R, Lukac P, Dekker L, Blaauw Y, Ter Bekke R, et al.
Europace
. 2025 Feb;
27(2).
PMID: 39992165
Aims: The optimal substrate ablation approach for post-myocardial infarction (MI) ventricular tachycardia (VT) is unknown. Proposed ablation targets are prone to individual interpretation making the ablation outcome potentially operator dependent....
2.
Zaman J, Khan A, Nielsen J, Kristiansen S, Kronborg M, Witt C, et al.
Heart Rhythm O2
. 2024 Sep;
5(8):543-550.
PMID: 39263613
Background: Electrogram dispersion identifies putative atrial fibrillation (AF) drivers in first time ablation procedures, with high acute termination rates and long-term outcomes akin to extensive ablation approaches. Its use in...
3.
Duytschaever M, Rackauskas G, De Potter T, Hansen J, Knecht S, Phlips T, et al.
Europace
. 2024 May;
26(5).
PMID: 38696675
Aims: Contact force (CF)-sensing radiofrequency (RF) catheters with an ablation index have shown reproducible outcomes for the treatment of atrial fibrillation (AF) in large multicentre studies. A dual-energy (DE) focal...
4.
Brouwer C, Hebe J, Nurnberg J, Nielsen J, Lukac P, de Riva M, et al.
JACC Clin Electrophysiol
. 2024 Apr;
10(6):1050-1060.
PMID: 38613544
Background: Atrial tachycardia (AT) and atrial fibrillation (AF) coexist in 30% of congenital heart disease (CHD) patients. Successful atrial tachycardia catheter ablation (ATCA) might prevent AF. Data on new-onset AF...
5.
Omara S, Glashan C, Tofig B, Leenknegt L, Dierckx H, Panfilov A, et al.
JACC Clin Electrophysiol
. 2024 Jan;
10(4):637-650.
PMID: 38276927
Background: Voltage mapping to detect ventricular scar is important for guiding catheter ablation, but the field-of-view of unipolar, bipolar, conventional, and microelectrodes as it relates to the extent of viable...
6.
Salamunova P, Krejci T, Rysanek P, Salon I, Kroupova J, Hubatova-Vackova A, et al.
Int J Pharm
. 2023 Jan;
634:122627.
PMID: 36693484
Nilotinib is a selective tyrosine-kinase inhibitor approved for the treatment of chronic myeloid leukemia. It is poorly soluble in aqueous media and has a low oral bioavailability. Nilotinib encapsulation into...
7.
Giehm-Reese M, Kronborg M, Lukac P, Kristiansen S, Jensen H, Gerdes C, et al.
J Interv Card Electrophysiol
. 2022 Jan;
63(3):699-707.
PMID: 35022997
Background: Contact force (CF)-guided catheter ablation (CA) is a novel technology developed to improve efficacy and reduce complications. In a randomised controlled trial (RCT), we previously documented that after 3 ...
8.
De Potter T, Grimaldi M, Jensen H, Kautzner J, Neuzil P, Vijgen J, et al.
J Atr Fibrillation
. 2021 Dec;
13(6):20200460.
PMID: 34950350
Background: A novel QDOT MICRO (Biosense Webster, Inc., Irvine, CA) catheter with optimized temperature control and microelectrodes was designed to incorporate real-time temperature sensing with contact force detection and microelectrodes...
9.
Brouwer C, Hebe J, Lukac P, Nurnberg J, Nielsen J, Silva M, et al.
Circ Arrhythm Electrophysiol
. 2021 Sep;
14(9):e009695.
PMID: 34465129
[Figure: see text].
10.
Rysanek P, Grus T, Lukac P, Kozlik P, Krizek T, Pozniak J, et al.
Br J Pharmacol
. 2021 Aug;
178(23):4663-4674.
PMID: 34365639
Background And Purpose: Lymphatic transport of drugs after oral administration is an important mechanism for absorption of highly lipophilic compounds. Direct measurement in lymph duct cannulated animals is the gold...